Femme et Homme
- | Pays :
- Canada
- Dominican Republic
- Honduras
- | Organes : -
- | Spécialités : -
Extrait
The purpose of this study is to investigate the immunogenicity, reactogenicity and safety of the new influenza vaccine GSK2282512A (FLU-Q-QIV) and compare its activity to the marketed vaccine Fluarix® (TIV) in young children 6 to 35 months of age.
Critère d'inclusion
- Influenza